Application 212689
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | TABLET;ORAL | 200MG;300MG | No | No |
| 002 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | TABLET;ORAL | 100MG;150MG | No | No |
| 003 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | TABLET;ORAL | 133MG;200MG | No | No |
| 004 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | TABLET;ORAL | 167MG;250MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212689-001 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | 200MG;300MG | TABLET / ORAL | AB | 2020-02-28 | |
| A212689-002 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | 100MG;150MG | TABLET / ORAL | AB | 2021-07-01 | |
| A212689-003 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | 133MG;200MG | TABLET / ORAL | AB | 2021-07-01 | |
| A212689-004 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | 167MG;250MG | TABLET / ORAL | AB | 2021-07-01 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212689-001 | AB |
| A212689-002 | AB |
| A212689-003 | AB |
| A212689-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A212689-001 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 200MG;300MG | TABLET / ORAL | AB | 2020-02-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212689-002 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 100MG;150MG | TABLET / ORAL | AB | 2021-07-01 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212689-003 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 133MG;200MG | TABLET / ORAL | AB | 2021-07-01 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212689-004 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 167MG;250MG | TABLET / ORAL | AB | 2021-07-01 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A212689-001 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 200MG;300MG | TABLET / ORAL | AB | 2020-02-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212689-002 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 100MG;150MG | TABLET / ORAL | AB | 2021-07-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212689-003 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 133MG;200MG | TABLET / ORAL | AB | 2021-07-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212689-004 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 167MG;250MG | TABLET / ORAL | AB | 2021-07-01 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212689-001 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 200MG;300MG | TABLET / ORAL | AB | 2020-02-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212689-002 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 100MG;150MG | TABLET / ORAL | AB | 2021-07-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212689-003 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 133MG;200MG | TABLET / ORAL | AB | 2021-07-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212689-004 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 167MG;250MG | TABLET / ORAL | AB | 2021-07-01 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212689-001 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 200MG;300MG | TABLET / ORAL | AB | 2020-02-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212689-002 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 100MG;150MG | TABLET / ORAL | AB | 2021-07-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212689-003 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 133MG;200MG | TABLET / ORAL | AB | 2021-07-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212689-004 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 167MG;250MG | TABLET / ORAL | AB | 2021-07-01 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212689-001 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 200MG;300MG | TABLET / ORAL | AB | 2020-02-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212689-002 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 100MG;150MG | TABLET / ORAL | AB | 2021-07-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212689-003 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 133MG;200MG | TABLET / ORAL | AB | 2021-07-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212689-004 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 167MG;250MG | TABLET / ORAL | AB | 2021-07-01 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212689-001 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 200MG;300MG | TABLET / ORAL | AB | 2020-02-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212689-002 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 100MG;150MG | TABLET / ORAL | AB | 2021-07-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212689-003 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 133MG;200MG | TABLET / ORAL | AB | 2021-07-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212689-004 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 167MG;250MG | TABLET / ORAL | AB | 2021-07-01 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212689-001 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 200MG;300MG | TABLET / ORAL | AB | 2020-02-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212689-002 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 100MG;150MG | TABLET / ORAL | AB | 2021-07-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212689-003 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 133MG;200MG | TABLET / ORAL | AB | 2021-07-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212689-004 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 167MG;250MG | TABLET / ORAL | AB | 2021-07-01 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212689-001 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 200MG;300MG | TABLET / ORAL | AB | 2020-02-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212689-002 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 100MG;150MG | TABLET / ORAL | AB | 2021-07-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212689-003 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 133MG;200MG | TABLET / ORAL | AB | 2021-07-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212689-004 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 167MG;250MG | TABLET / ORAL | AB | 2021-07-01 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212689-001 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 200MG;300MG | TABLET / ORAL | AB | 2020-02-28 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212689-002 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 100MG;150MG | TABLET / ORAL | AB | 2021-07-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212689-003 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 133MG;200MG | TABLET / ORAL | AB | 2021-07-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212689-004 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 167MG;250MG | TABLET / ORAL | AB | 2021-07-01 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212689-001 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 200MG;300MG | TABLET / ORAL | AB | 2020-02-28 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212689-002 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 100MG;150MG | TABLET / ORAL | AB | 2021-07-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212689-003 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 133MG;200MG | TABLET / ORAL | AB | 2021-07-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212689-004 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 167MG;250MG | TABLET / ORAL | AB | 2021-07-01 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A212689-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212689-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212689-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212689-004 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A212689-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A212689-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A212689-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A212689-004 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A212689-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212689-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212689-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212689-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212689-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212689-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212689-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212689-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A212689-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212689-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212689-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212689-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212689-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212689-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212689-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212689-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212689-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212689-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212689-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212689-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212689-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212689-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212689-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212689-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212689-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212689-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212689-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212689-004 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212689-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212689-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212689-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212689-004 | AB | 1 | 5bbf6a4d5a75… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Emtricitabine and tenofovir disoproxil fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Zydus Lifesciences Limited | a0ee89b6-72c3-4b99-8d1c-d7473f1d5ef3 | 2024-11-28 | 212689 ANDA212689 70771-1620 70771-1709 70771-1622 70771-1621 | |
| Emtricitabine and tenofovir disoproxil fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Zydus Pharmaceuticals USA Inc. | 7def7a95-e69e-4985-974a-efacadcecc95 | 2024-05-10 | Boxed warning, Warnings, Adverse reactions | 212689 ANDA212689 70710-1366 70710-1365 70710-1367 70710-1364 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70710-1364 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 70710-1364 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1365 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 70710-1365 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1366 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 70710-1366 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1367 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 70710-1367 | Emtricitabine and Tenofovir Disoproxil Fumarate | Emtricitabine and Tenofovir Disoproxil Fumarate | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1367 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70771-1594 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Cadila Healthcare Limited | ANDA | Current |
| 70771-1620 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Cadila Healthcare Limited | ANDA | Current |
| 70771-1620 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Zydus Lifesciences Limited | ANDA | Current |
| 70771-1621 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Cadila Healthcare Limited | ANDA | Current |
| 70771-1621 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Zydus Lifesciences Limited | ANDA | Current |
| 70771-1622 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Cadila Healthcare Limited | ANDA | Current |
| 70771-1622 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Zydus Lifesciences Limited | ANDA | Current |
| 70771-1709 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Cadila Healthcare Limited | ANDA | Current |
| 70771-1709 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate | Zydus Lifesciences Limited | ANDA | Current |
| 72189-227 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | DIRECT RX | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 62248 | ORIG | 2020-03-23 |